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4042 | Chem. Sci., 2015, 6, 4042–4048peptoid-based ligands for the
removal of cadmium from biological media†
Abigail S. Knight,a Effie Y. Zhoua and Matthew B. Francis*ab
Cadmium poisoning poses a serious health concern due to cadmium's increasing industrial use, yet there is
currently no recommended treatment. The selective coordination of cadmium in a biological
environment—i.e. in the presence of serum ions, small molecules, and proteins—is a difficult task. To
address this challenge, a combinatorial library of peptoid-based ligands has been evaluated to identify
structures that selectively bind to cadmium in human serum with minimal chelation of essential metal
ions. Eighteen unique ligands were identified in this screening procedure, and the binding affinity of each
was measured using metal titrations monitored by UV-vis spectroscopy. To evaluate the significance of
each chelating moiety, sequence rearrangements and substitutions were examined. Analysis of a metal–
ligand complex by NMR spectroscopy highlighted the importance of particular residues. Depletion
experiments were performed in serum mimetics and human serum with exogenously added cadmium.
These depletion experiments were used to compare and demonstrate the ability of these peptoids to
remove cadmium from blood-like mixtures. In one of these depletion experiments, the peptoid
sequence was able to deplete the cadmium to a level comparable to the reported acute toxicity limit.
Evaluation of the metal selectivity in buffered solution and in human serum was performed to verify
minimal off-target binding. These studies highlight a screening platform for the identification of metal–
ligands that are capable of binding in a complex environment. They additionally demonstrate the
potential utility of biologically-compatible ligands for the treatment of heavy metal poisoning.Introduction
For the past y years it has been well established that
cadmium is hazardous to human health, but the industrial use
of this metal has continued to increase world-wide.1 Cadmium
exposure leads to a particularly problematic form of heavy metal
poisoning due to the lack of current treatment options.2
Cadmium has been identied by the International Agency for
Cancer as a group-1 carcinogen, and it is listed by the Envi-
ronmental Protection Agency as one of 126 priority pollutants.3
Despite this toxicity being well accepted, it is not fully under-
stood how cadmium interacts with biological molecules to
produce these deleterious effects.4 One current hypothesis
suggests that Cd2+ can interfere with DNA repair and protein
function, and that it can mediate the production of reactive
oxygen species despite not acting directly as an oxidant.4–6 Two
biological molecules, metallothionein proteins and gluta-
thione, can aid in the clearance of Cd2+. Unfortunately, metal-
lothioneins can increase the circulation time of cadmium ions,7ifornia, Berkeley, CA, 94720, USA. E-mail:
eley National Laboratory, Berkeley, CA,
tion (ESI) available. See DOI:and the glutathione depletion can have debilitating effects on
cells, potentially including the observed oxidative stress
responses.8
Evolution does not appear to have provided a strategy for
clearing Cd2+, and unfortunately there is also no therapeutic
solution to cadmium poisoning. Chelation therapy has been
proven to be benecial for some heavy metals including lead
and mercury, and has become the mainstay of treatment for
acute poisoning with these metals.9 Simple small molecules,
including EDTA, dimercaptosuccininc acid, and 2,3-dimer-
caprol, are commonly used for these purposes. One major
concern with the administration of chelation therapy is that
despite the increased affinity of many small molecule chelators
for their heavy metal targets, the signicant excess of other
biological ions makes elements such as Ca2+ their primary
target. This leads to a variety of hazardous side effects.10 There
exists a clear need for non-toxic ligands with selective affinity for
cadmium that could be introduced as a chelation therapy
alternatives. Additionally, such ligands could be integrated into
other blood treatment strategies, such as dialysis platforms.
Selective chelation of Cd2+ in blood is a considerable chal-
lenge due to the signicant excess of competing ions and
ligands, including serum small molecules and proteins. The
rational design of a ligand for this application is particularly
difficult due to the chemical similarity between Cd2+ andThis journal is © The Royal Society of Chemistry 2015
Fig. 1 Peptoid library schematic. The diagram depicts the photo-
cleavable residue, linker, and peptoid ligand structure with variable
positions represented as “Xn” and “Turn”. The seven “R” residues were
incorporated into each of the four peptoid positions, and the three D-
proline based turns were incorporated into the “Turn” position. The
overall library consists of 7203 compounds.
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View Article Onlinebiologically essential Zn2+. Peptide-based combinatorial
approaches have been demonstrated to successfully identify
ligands as catalysts and metal tags,11–14 and pioneering work on
peptide-based synthetic ionophores was completed by W. C.
Still.15 We propose that peptoids, or N-substituted glycine olig-
omers,16 offer distinct advantages for the treatment of cadmium
poisoning. The ability of these peptidomimetics to access
unique conformations and the variety of available monomers
make peptoids particularly valuable as ligands, and their metal
binding capacity has been recently demonstrated.17–21 Addi-
tionally, their improved in vivo stability provides exceptional
advantages for a therapeutic application.22–24 In this work, we
have developed an expanded peptoid-based library and used it
to identify multiple ligands with the ability to bind Cd2+ in
human serum. One of these structures was found to reduce the
concentration of Cd2+ to a level comparable with the reported
limit of acute toxicity.25 These studies therefore reinforce the
unique capabilities of peptoid-based ligands through the
development of structures with unparalleled ion-selectivity in a
particularly complex biological medium.
Results and discussion
Library design and synthesis
To approach the challenge of developing a high affinity ligand
that can bind to cadmium in the complex medium of human
blood, we synthesized a peptoid-based library designed to
decrease the number of available conformations and form a
binding “pocket.”26 In our previous work, a peptoid tetramer
was synthesized and demonstrated to have the potential for
selective binding; additionally it was discovered that the
incorporation of a D-proline-based turn increased the metal
affinity of the ligand.17 Based on this observation a library
incorporating D-proline and three turn moieties (Glycine, 1PEG,
and 2PEG) was designed (Fig. 1), with the objective of discov-
ering higher affinity and more selective structures. Within this
work we will dene selectivity as the preferential binding of
cadmium in the presence of biologically relevant concentra-
tions of competing metal ions.
The library members were synthesized on 140–170 mm PEG-
graed polystyrene resin, which is compatible with both
organic solvents and water for the synthesis and screening
steps, respectively. The rst residue incorporated was a photo-
cleavable moiety to allow cleavage and sequence identication
using MALDI-TOF MS/MS. This residue and the following three
linker groups were added using standard solid-phase peptide
chemistry. Previously, a residue with an isotopic tag (79Br/81Br)
was included to identify library member mass signals; however,
due to the decreased signal-to-noise ratio we chose not to
include this residue for this screen. To increase the mass of the
cleaved structures and the distance between the ligands and the
resin, three aminohexanoic acid residues were combined to
form a linker. The ligand itself was synthesized using a
combination of the submonomer method of peptoid synthesis27
with chloroacetic acid to allow incorporation of heterocyclic
side chains28 and standard Fmoc-peptide synthesis. Split-and-
pool synthesis was used to create a library of 7203 members.This journal is © The Royal Society of Chemistry 2015Adducts between the histamine and chloroacetic acid were
cleaved with 4-methylpiperidine28 and acid labile protecting
groups on the monomers were cleaved with triuoroacetic acid.Screening for selective cadmium affinity
To identify ligands that could bind cadmium in the presence of
the proteins, small molecules, and other ions in human serum,
a screening medium that contained reproducible concentra-
tions of these components was designed. A serum replacement,
intended as a media supplement for mammalian cell culture,
was obtained from Life Technologies. Excess biologically rele-
vant transition metals (Fe2+, Mn2+, Zn2+), typically present in
high concentrations or unbound in serum,29,30 were considered
to be the main competing ions. These were added to the serum
replacement (2.5 mM each) in addition to Cd2+ (250 mM). An
outline of the screening procedure is shown in Fig. 2a. A library
aliquot pre-swelled in water was exposed to this screening
medium for 1–4 h before being isolated via ltration and rinsed
with water. Because cadmium typically forms colorless
complexes, a dye that forms distinctly colored complexes with
these ions was applied to assist in the detection of ligands
within the library. The dye was applied in ethanol, which aer
evaporation le the metal and cadion dye31,32 trapped within the
beads. The cadion dye is yellow in water and blue in ethanol,
leading to the yellow, blue, and green beads apparent in Fig. 2a.
However, a bright pink color occurs upon complexation of
cadmium (color with relevant metals shown in Fig. S1a†),
allowing unambiguous identication of the cadmium chelators
using a light microscope.
The dye and complexed ions were removed from the selected
beads to prepare for sequencing using MS/MS (see the ESI† forChem. Sci., 2015, 6, 4042–4048 | 4043
Fig. 2 Overview of the screening procedure and measured Cd2+
binding affinities of identified sequences and variants. (a) An outline of
the screening procedure is shown with a representative photograph of
the library members after the staining procedure. The screening
medium included serum replacement, added transition metal ions
found free in blood (Fe2+, Mn2+, and Zn2+, 250 mM) and cadmium (25
mM). After incubation of the library with the screening medium, the
library was rinsed and treated with cadion dye. (b) Five of the eighteen
identified sequences are listed. All dissociation constants displayed
were measured using titrations in HEPES buffer (10 mM, pH 7) moni-
tored by UV-vis spectroscopy. A logistic fit was applied to the data and
the inflection point was used to approximate the Kd values. A 1 : 1
binding mode was assumed. c) Variants of the highest affinity
sequence, Sequence 2, are shown. 2A–C are scrambled sequences in
which the thiol containing monomer (Nthe) was switched with each
residue. 2Y and 2Z are structures in which the acid containing moieties
(Ncm) were replaced with Nbu to investigate the significance of each
residue. The binding was characterized using the same method as (b);
however, for Z, the affinity was too low to measure. All error bars
represent the standard error of the logistic fit.
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
M
ay
 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
8/
11
/2
01
7 
15
:5
1:
38
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinedetails). Photocleavage was performed, but as depicted in ESI,
Fig. S1,† the photocleavage led to a mass loss of 32 for the
identied sequences. It was assumed that this loss corre-
sponded to desulfurization under the photolysis conditions. To
verify the mass of the original structure, the screening proce-
dure was repeated and the selected beads were incubated with
N-ethylmaleimide (NEM) before photocleavage to cap the thiol
residues and prevent any undesired photochemical reactions
(ESI, Fig. S1d†). This procedure yielded an individual bead with
both the NEM capped structure and the uncapped structure. By
comparing the MS/MS fragmentation patterns of the two
structures, it was clear that the mass of 32 was lost from an
N-terminal Nthe residue during the photocleavage step.4044 | Chem. Sci., 2015, 6, 4042–4048Aer multiple rounds of screening, eighteen unique
sequences were identied (full structures are shown in ESI,
Fig. S2†). All but two of these structures contained an
N-terminal Nthe residue, with the negatively charged residues
(Ncm and Nce) common in positions X2 and X3. Interestingly,
the Nthe group was not identied in other positions. There was
no consensus for the turn moiety, and many of the unique
ligands varied only by that residue. The nal position, X4, was
mostly lled by hydrophobic residues (Nbu and Npip).Binding affinity characterization
To compare the affinity of each of the structures for Cd2+,
titrations of Cd2+ into solutions of each peptoid were completed
and monitored by UV-vis spectroscopy. The peptoid structures
were prepared by synthesis on Rink Amide resin and puried by
reverse phase HPLC aer cleavage from the resin. Example
mass-spectra of sequences aer purication are shown in ESI,
Fig. S3.† The titrations were monitored at a wavelength of
245 nm. A broad peak spanning from 260 nm through the
lowest wavelength scanned (220 nm) was apparent; 245 nm was
chosen to avoid wavelengths where the solvent and isolated
peptoid would absorb. Absorbance at these low wavelengths is
characteristic of cadmium thiolate clusters.33 The data sets were
t to logistic curves and the inection points were used to
determine the dissociation constants (ESI, Fig. S4†). The stoi-
chiometry of the complex formed is difficult to determine due to
other competing reactions (e.g. disulde formation). The
complexes did not remaining intact aer MALDI-TOF MS ioni-
zation, and thus could not be detected directly. In this work, we
assume a 1 : 1 ratio based on previous characterization of
similar complexes formed with glutathione at comparable
concentrations.34 The Kd for the highest affinity peptoid,
Sequence 2, and the highest affinity structures that were iden-
tiedmultiple times in the screen (Sequences 1, 3, 9, and 14) are
shown in Fig. 2b. Generally, the Kd values ranged from 5–40 mM.
As a preliminary evaluation of the selectivity of the peptoids, the
same titration was performed with Sequence 2 and Zn2+, and an
eight-fold lower affinity was observed (ESI, Fig. S5c†). To
compare the identied sequences to a similar biological
compound, a titration was performed with glutathione and
cadmium. Glutathione had an affinity too poor to characterize
with the titration (ESI, Fig. S5b†).
To understand the mechanism of Cd2+ binding and inform
any future ligand evolution, the specic interactions of each
residue with Cd2+ were probed. To begin, the location of the
Nthe residue (at the N-terminus) was switched with each of the
other residues in the highest affinity ligand (Sequence 2). The
structures and measured Kd values are shown in Fig. 2c as
variants 2A, 2B, and 2C. These rearrangements yielded four- to
eight-fold decreases in affinity, indicating not only the necessity
of the Nthe residue, but also the importance of its location in
the ligand. To analyze the importance of each of the two
carboxylic acids, variants were synthesized with Nbu residues
replacing the Ncm functionalities (variants 2Y and 2Z). Each of
these had a signicantly decreased affinity, and 2Z (containingThis journal is © The Royal Society of Chemistry 2015
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View Article OnlineNbu at the X3 position) had a Kd value larger than what could be
determined with the titration (ESI, Fig. S5a†).Complex characterization with NMR
Synthesizing variants conrmed the importance of the pep-
toid moieties, but NMR was necessary to identify which resi-
dues were directly coordinating the Cd2+. Cadmium is
commonly used as a surrogate for other divalent cations when
studying proteins by NMR, but few complexes have been
characterized in order to probe small molecule ligand–Cd2+
interactions.35 Sequence 2 was selected for this analysis, as it
was identied as the highest affinity sequence. An initial 1H-
NMR spectrum of the peptoid alone (Fig. 3) had notably fewer
rotamers than the tetramers we have previously studied.17 A
3 : 1 ratio of two distinct conformers was apparent instead of
the overlapping signals of many rotamers. This conforma-
tional restriction could be due to the unique tertiary amines in
this structure, but we propose that the two conformers result
from the cis and trans states available to the D-proline.36 There
have been many previous reports of the structure of peptoids
with chiral centers in the side chains.37,38 However, an evalu-
ation of the available rotamers has not been previously
reported.
From 1H TOCSY (ESI, Fig. S6a†) and 1H–13C HMBC (ESI,
Fig. S6b and S7a†) spectra, each of the relevant signals from
Sequence 2 was assigned. The HSQC spectrum shown in Fig. 3
(full spectrum in ESI, Fig. S7b†) displays the behavior of
Sequence 2 upon titration with Cd2+. With increasing equiva-
lents of Cd2+ the methylene peaks of the Nthe residue (Fig. 3,
signals A and B), in addition to those alpha to the N-terminus
(Fig. 3, signal C), displayed distinct chemical shis. The shis
observed in the protons in the Nthe residue are comparable toFig. 3 1H–13C HSQC NMR (900 MHz) spectrum of Sequence 2
(500 mM) in the presence of Cd2+. Resonances that shift upon the
addition of Cd2+ are highlighted. All spectra were obtained in 10 mM
phosphate buffer (pH 7) with 10% D2O.
This journal is © The Royal Society of Chemistry 2015those observed for the methylene hydrogens in glutathione.39
However, the methylene hydrogens in glutathione display
separate diastereotopic signals whereas the corresponding
methylene hydrogens in Sequence 2 are identical. A possible
binding mode supported by this observation is that the thiol
and carboxylic acids coordinate the Cd2+ in a symmetrical
fashion.Depletion of cadmium from biological media
The initial characterization conrmed the affinity of the
identied structures for Cd2+. The next step was to conrm
the selectivity of the ligands within the complex mixture of
ions, small molecules, and proteins present in human serum.
Since affinity does not necessarily correlate with selectivity,
the four highest affinity peptoids that were repeatedly iden-
tied in the screening process (Sequences 1, 3, 9, and 14) and
the highest affinity ligand (Sequence 2) were resynthesized on
a Tentagel NH2 support compatible with both organic
solvents and water (sequences are listed in Fig. 2b, and
MALDI-TOF spectra are displayed in ESI Fig. S3†). Each of
these ligands was exposed to three biological mixtures: (1)
serum replacement, (2) serum replacement with the addition
of relevant transition metals (100 mM: Fe2+, Mn2+, Zn2+), and
(3) human serum from AB clotted whole blood. Each of these
experiments contained an added cadmium concentration of
10 mM with a ten molar equivalent excess of the peptoid
ligands on the resin.
Similar trends were apparent in each of the serum solu-
tions evaluated (Fig. 4a and b). The most cadmium was
depleted from the serum replacement alone, and most of the
peptoids were comparably effective in the serum replacement
with transition metals and the human serum, validating the
selection of the former as a screening medium. Notably,
Sequence 2, the ligand with the highest affinity for Cd2+, was
outperformed by the other sequences in the serum replace-
ment and human serum. Since the addition of the transition
metals did not impact the efficacy of Sequence 2, it is likely
that the binding was impeded by additional components of
the serum, such as other ions or proteins. Sequence 14 devi-
ated from the consensus exhibited by the other sequences
evaluated (thiol–carboxylic acid–carboxylic acid–butyl) by
including Npip in the middle of the structure; therefore, it is
unsurprising that it was not as selective as the other ligands.
Sequences 1, 3 and 9 appeared to perform equivalently in each
medium, as might be expected by the minor differences in
their structures.
In chelation therapies, it is feasible and common to use
large excesses of chelating agents. As one example, studies
investigating EDTA as a chelation therapy used up to 500
equivalents (1.5 g kg1) of the small molecule relative to the
cadmium concentration in an in vivo study.40 To determine how
effective the peptoids could be at higher molar ratios, Cd2+ was
added to human serum at concentrations of 1 and 10 mM and
exposed to various amounts of Sequence 3 on resin, as a
representative structure (Fig. 4c). Sequence 3 (structure in
Fig. 5b) was chosen as a representative ligand, but weChem. Sci., 2015, 6, 4042–4048 | 4045
Fig. 4 Evaluation of Cd2+ binding efficacy of peptoid ligands in human
serum andmimetic solutions. (a) Serum replacement with and without
the addition of biologically relevant transitionmetals (Fe2+, Mn2+, Zn2+,
100 mM) and (b) human serumwere prepared with a toxic level of Cd2+
(10 mM) and exposed to five peptoid sequences attached to the resin
(10 eq relative to Cd2+). The amount of cadmium remaining after a 24 h
incubation was measured with ICP-OES. The cadmium concentration
in the initial solution and a sample with no resin are reported, in
addition to those exposed to ligands. (c) The depletion ability of
Sequence 3 in human serum was additionally evaluated with more
equivalents (X ¼ eq relative to Cd2+) of the ligand and at a lower
concentration of Cd2+ (1 mM). All error bars represent the standard
errors of each sample set (n ¼ 3).
Fig. 5 Evaluation of selectivity of peptoid ligands for Cd2+ in the
presence of biological divalent cations in human serum. Two
concentrations of cadmium (1 mM and 10 mM) were exposed to
Sequence 3 (100 mM on resin) for 24 h, and the remaining concen-
trations of each of the divalent cations were measured using ICP-OES.
All error bars represent the standard errors of each sample set (n ¼ 5).
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View Article Onlineanticipate similar results with Sequences 1 and 9. Penicillin
and streptomycin were added to these serum samples to
prevent the growth of bacteria, which could accumulate in the
resin and block ligand access. In the 10 mM Cd2+ serum
samples, 10 and 50 molar equivalents of Sequence 3 on resin
were incubated with the samples and removed 73% and 94%
respectively of the cadmium. More equivalents of the peptoid
could not be added to these samples while still allowing full
swelling of the resin. Therefore, to demonstrate further the
depletion ability of the ligand, Sequence 3 was added to human
serum samples with 1 mM Cd2+. The same quantities of resin
containing Sequence 3 were added to these samples, and up to
56% of the Cd2+ was removed.
Although antibiotics were added to the samples to prevent
bacteria from growing and accumulating in the resin used for
the assay, it is still likely that larger proteins in the serum pre-
vented the access of some ligands in the pores of the resin.
Notably, even with the limitations of this assay, we were able to
bring the cadmium concentration down to 0.51 mM—compa-
rable to the limit for acute toxicity in whole blood reported by
theMayo Clinic (0.45 mM).25 If these ligands were integrated into
dialysis systems that have been optimized for blood treatment,4046 | Chem. Sci., 2015, 6, 4042–4048it is likely that blood cadmium concentration could be reduced
to values well below this limit.Evaluation of ligand selectivity
Final experiments sought to evaluate the selectivity of the
identied peptoid ligands more directly. To explore this,
Sequence 3 was exposed to a solution with relevant ions (Fe2+,
Mg2+, Mn2+, Ca2+, Zn2+, Cu2+, Ni2+, Cd2+ – approximately 10 mm)
in a buffer compatible with each of these ions, bis–Tris (10 mM,
pH 7.4). The samples were agitated with the beads using a
nutator for 24 h at room temperature. The ligands were at a
lower molar excess than in the serum assays (5 equiv instead of
10 equiv). In this solution, the ligands were still able to deplete
the solution of over 70% of the Cd2+. As depicted in Fig. S8,†
cadmium was the most signicant ion depleted though the
concentrations of the later transition metals were also lowered
slightly.
These depletion selectivity experiments were next repeated
in human serum using the native concentrations of the metal
ions (Fig. 5). Serum samples with Cd2+ added at 1 and 10 mM
were exposed to Sequence 3 on resin, and the remaining
concentrations of Ca2+, Fe2+, Mg2+, Cu2+, Zn2+, and Cd2+ were
measured. No signicant change was measured for Mg2+, Ca2+,
Cu2+, and Fe2+. Additionally, although the original concentra-
tion of Cu2+ and Zn2+ measured in the serum samples were
close to 10 mM,much less was depleted from the serum samples
than from the buffer samples. This is possibly due to native
interactions of the ions with serum proteins and small mole-
cules. Due to the chemical similarities between Cd2+ and Zn2+
(both being d10 metal ions) there are very few ligands with a
selective affinity for cadmium.41 While a variety of small mole-
cules have been developed as uorescent sensors for cadmium,This journal is © The Royal Society of Chemistry 2015
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View Article Onlinemany are incompatible with water or have uorescence variance
due to factors other than specicity.42Conclusions
Through this work, we have demonstrated a combinatorial
platform for the identication of readily-synthesized ligands
capable of selectively chelating Cd2+ in a complex environment.
Using the identied ligands, we demonstrated the capacity to
remove cadmium from human serum samples with unprece-
dented performance. These molecules can be applied not only
to the treatment of cadmium poisoning, but also in the ongoing
investigations of the mechanisms of its toxicity. We are
currently exploring the development of simple economical
devices for the detection and treatment of cadmium poisoning
by immobilizing these ligands on alternative supports. Addi-
tionally, we are continuing to explore the applications of this
ligand identication platform in a variety of elds, including
metal separations and actinide sequestration.Acknowledgements
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